The expression of antisense vascular endothelial growth factor (VEGF) sequences inhibits intracranial C6 glioma growth in vivo by suppressing tumour angiogenesis

Journal of Clinical Neuroscience

Volumn 3, Issue 4, 1996, Pages 366-372

  Saleh, Mary ^a,c   Vasilopoulos, Kally ^a   Stylli, Stan S ^a   Kaye, Andrew H ^a   Wilks, Andrew F ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Angiogenesis; Antisense; Endothelium; Glioma; VEGF

Indexed keywords

EID: 0001246010     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(96)90035-1     Document Type: Article

References (24)

1. Kaye AH, Hill JS. Photodynamic therapy of brain tumors [Review]. Ann Acad Med Singapore 1993; 22: 470-481.
2. Gillaspy GE, Mapstone TB, Samols D, Goldthwait DA. Transcriptional patterns of growth factors and proto-oncogenes in human glioblastomas and normal glial cells. Cancer Letters 1992; 65: 55-60.
3. Pedersen P, Ness GO, Engerbraaten O, Bjerkvig R, Lillehaug JH, Laerum OD. Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-a, bFGF, IL-2] on gliorna speheroid growth, migration and invasion. Int J Cancer 1994; 56: 255-261.
4. Folkman J. Anti-angiogenesis: new concepts of therapy of solid tumors. Annals of Surgery 1972; 175: 409-416.
5. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-848.
6. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
7. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1993; 359: 845-848.
8. Shweiki D, Neeman M, Hin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumour angiogenesis. Proc Natl Acad Sci USA 1995; 92: 768-772.
9. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
10. Keck PJ, Hauser SD, Krivi G et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-1312.
11. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Molecular Endocinology 1991; 5: 1806-1814.
12. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-532.
13. Millauer B, Wizigmann Voos S, Schnurch H et al High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-846.
14. Plate KH, Breier G, Weich HA, Mennel HA, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanism. Int J Cancer 1994; 59: 520-529.
15. De Vries, C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-991.
16. Terman BI, Dougher-Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochemistry and Biophysics Research Communications 1993; 187: 1579-1586.
17. Oelrichs RB, Reid HH, Bernard O, Ziemiecki A, Wilks AF. NYK/FLK-1: A putative receptor protein tyrosine kinase isolated from ElO embryonic neuroepitheium is expressed in endothelial cells of the developing embryo. Oncogene 1993; 8: 11-18.
18. Kim KJ, Li B, Winer J et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841-844.
19. Millauer B, Shawver LK, Plate KL, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994; 367: 576-579.
20. Saleh M, Stacker S. Inhibition of growth of C6 glioma cells in vivo by expression of antisense Vascular Endothelial Growth Factor (VEGF) sequence. Cancer Research 1996 (In Press).
21. Mizushima S, Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Research 1990; 18: 5322.
22. Graham FL, Eb AJv. Transformation of rat cells by DNA of human adenovirus 5. Virology 1973; 54: 536-539.
23. Woodburn KW, Hill JS, Stylli S, Kaye AH, Reiss JA, Phillips DR. Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy. Br J Cancer 1994; 70: 398-400.
24. Folkman J. Tumour angiogenesis: A possible control point in tumour growth. Ann Int Med 1975; 82: 96-100.